United States · FDA National Drug Code directory
Propafenone Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 59651-278_ef0c975d-08ee-4649-9017-4f7f1a2981a1
- Product NDC
- 59651-278
- Form
- CAPSULE, EXTENDED RELEASE
- Composition / generic term
- Propafenone Hydrochloride
- Labeler
- Aurobindo Pharma Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20230221
- Source listing expiry
- 20261231
Source-listed ingredients
- PROPAFENONE HYDROCHLORIDE — 425 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (59651-278-05) · 59651-278-05
- 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (59651-278-60) · 59651-278-60
- 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (59651-278-90) · 59651-278-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →